![](https://www.thehindu.com/theme/images/og-image.png)
Dr. Reddy’s inks pact to market Takeda’s novel gastrointestinal drug Vonoprazan in India
Drugmaker Dr. Reddy’s Laboratories has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company to commercialise Vonoprazan tablets in India. A novel, orally active potassium competitive acid blocker (PCAB) Vonoprazan is …